Articles about T-cells

Adaptive Biotech revenue up 25%; company launches T-cell test for past COVID-19 infections

Seattle-based Adaptive Biotechnologies, which develops technology to sequence the human immune system to diagnose and treat disease, posted revenue of… Read More

Microsoft-backed universal blood test could start diagnosing disease ‘within a small number of years’

REDMOND — A groundbreaking system that would use artificial intelligence to diagnose several diseases from a single blood test may… Read More

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to $2 billion

Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More

Microsoft and Adaptive Biotechnologies go live with AI engine for universal diagnostic blood test

It’s been one day short of a year since Microsoft partnered with Adaptive Biotechnologies to create a blood test with… Read More

Fast-growing Adaptive Biotechnologies appoints president of new therapeutics division

Adaptive Biotechnologies, the heavily-funded Seattle bioinformatics company, today announced that Diego Miralles will become the president of a new division of… Read More